Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
15978

References

Authors, et al. Title Journal Year Volume Pages
Hao Liu N-Linked Glycosylation at an Appropriate Position in the Pre-S2 Domain Is Critical for Cellular and Humoral Immunity against Middle HBV Surface Antigen Tohoku J Exp Med 2015 236 131-8
Sheida Shariat Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects Iran J Basic Med Sci 2015 18 506-13
Meng Xu Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype J Immunol 2015 194 4997-5006
Shujie Liao A novel "priming-boosting" strategy for immune interventions in cervical cancer Mol Immunol 2015 64 295-305
Peter Soema Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine Pharm Res 2015 32 1505-15
Yannick Fuchs Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines Clin Immunol 2015 157 216-25
Yuhua Li Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen Cancer Immunol Immunother 2015 64 259-69
Zhi-Liang Duan Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2 Virus Res 2015 196 5-12
Huadong Wang Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO PLoS One 2015 10 e0119964
S Huber Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets PLoS One 2015 10 e0127969